Mikihiro Fujiya Selected Research

carbazochrome (Adona)

10/2022

Carbazochrome sodium sulfonate is not effective for prevention of post-gastric endoscopic submucosal dissection bleeding: A retrospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mikihiro Fujiya Research Topics

Disease

39	Neoplasms (Cancer) 11/2022 - 08/2002
15	Inflammation (Inflammations) 01/2022 - 04/2006
10	Colitis 01/2021 - 01/2010
9	Stomach Neoplasms (Stomach Cancer) 01/2022 - 08/2002
9	Crohn Disease (Crohn's Disease) 01/2022 - 04/2006
8	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 08/2002
8	Adenocarcinoma 07/2021 - 01/2004
7	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 06/2008
7	Ulcerative Colitis 01/2022 - 04/2006
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2010
6	Iron Overload 03/2017 - 11/2011
6	Colonic Neoplasms (Colon Cancer) 01/2017 - 01/2003
5	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 04/2012
5	Infections 11/2018 - 03/2009
4	Hemorrhage 10/2022 - 10/2011
4	Carcinoma (Carcinomatosis) 01/2021 - 04/2006
4	Non-alcoholic Fatty Liver Disease 06/2020 - 08/2014
4	Fibrosis (Cirrhosis) 01/2018 - 08/2015
3	Pathologic Constriction (Stenosis) 03/2022 - 08/2002
3	Hypersensitivity (Allergy) 01/2022 - 08/2017
3	Hypoxia (Hypoxemia) 01/2022 - 08/2010
3	Liver Diseases (Liver Disease) 01/2022 - 01/2015
3	Carcinogenesis 01/2021 - 03/2009
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2019
2	Chemical and Drug Induced Liver Injury 01/2022 - 06/2019
2	Diarrhea 01/2022 - 02/2010
2	Melanoma (Melanoma, Malignant) 01/2022 - 10/2021
2	Diverticular Diseases 01/2022 - 08/2015
2	Wounds and Injuries (Trauma) 11/2021 - 07/2015
2	Ascites 08/2021 - 08/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2016
2	Neoplasms, Cystic, Mucinous, and Serous 12/2020 - 01/2018
2	Lymphatic Metastasis 01/2019 - 08/2002
2	Abdominal Pain (Pain, Abdominal) 08/2017 - 06/2016
2	Iron Deficiencies 07/2017 - 12/2015
2	Enteritis 07/2015 - 01/2014
2	Disseminated Intravascular Coagulation 01/2014 - 01/2012
2	Microsatellite Instability 05/2012 - 03/2009

Drug/Important Bio-Agent (IBA)

12	Messenger RNA (mRNA)IBA 10/2022 - 06/2008
11	IronIBA 07/2017 - 03/2011
9	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2011
6	Biomarkers (Surrogate Marker)IBA 08/2021 - 03/2009
6	CytokinesIBA 08/2014 - 04/2006
5	Small Interfering RNA (siRNA)IBA 10/2022 - 06/2013
5	PolyphosphatesIBA 11/2021 - 08/2015
5	Dextrans (Dextran)FDA Link 11/2018 - 11/2011
5	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2018 - 11/2011
4	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 10/2022 - 11/2015
4	Pharmaceutical PreparationsIBA 01/2022 - 02/2012
4	MucinsIBA 01/2022 - 01/2003
4	Biological ProductsIBA 01/2022 - 01/2003
4	Infliximab (Remicade)FDA Link 01/2022 - 01/2013
4	FerrichromeIBA 01/2021 - 10/2016
4	Dextran SulfateIBA 01/2021 - 01/2010
4	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2015
3	NivolumabIBA 01/2022 - 01/2019
3	Immune Checkpoint InhibitorsIBA 01/2022 - 06/2020
3	Capsules (Microcapsules)IBA 01/2022 - 08/2010
3	MicroRNAs (MicroRNA)IBA 11/2021 - 06/2013
3	SteroidsIBA 10/2021 - 01/2019
3	AntibodiesIBA 07/2021 - 07/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 04/2006
3	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 04/2010
3	RibonucleoproteinsIBA 06/2020 - 11/2015
3	Antimicrobial PeptidesIBA 11/2018 - 01/2010
3	Indicators and Reagents (Reagents)IBA 11/2017 - 12/2015
3	HepcidinsIBA 03/2017 - 02/2014
3	Cadherins (E-Cadherin)IBA 09/2013 - 01/2004
2	Immunologic Factors (Immunomodulators)IBA 11/2022 - 01/2013
2	Biosimilar PharmaceuticalsIBA 01/2022 - 10/2021
2	CateninsIBA 01/2022 - 01/2017
2	heptelidic acidIBA 01/2022 - 01/2021
2	CT-P13IBA 01/2022 - 10/2021
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 08/2021 - 01/2020
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 06/2021 - 01/2020
2	Diatrizoate Meglumine (Gastrograffin)FDA LinkGeneric 01/2021 - 03/2011
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2020
2	Octreotide (Sandostatin)FDA LinkGeneric 01/2021 - 01/2011
2	Codon (Codons)IBA 06/2020 - 08/2002
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 04/2012
2	Ferritins (Ferritin)IBA 07/2017 - 12/2015
2	12,13- dihydro- N- methyl- 6,11,13- trioxo- 5H- benzo(4,5)cyclohepta(1,2- b)naphthalen- 5,12- imineIBA 01/2017 - 01/2014
2	Keratins (Keratin)IBA 08/2016 - 01/2016
2	Heterogeneous Nuclear Ribonucleoprotein A1IBA 11/2015 - 07/2015
2	CollagenIBA 08/2015 - 02/2010
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2015 - 06/2013
2	BariumIBA 08/2015 - 10/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2014 - 01/2013
2	Dacarbazine (DIC)FDA LinkGeneric 01/2014 - 01/2012
2	ThrombomodulinIBA 01/2014 - 01/2012
2	Monoclonal AntibodiesIBA 05/2012 - 03/2009

Therapy/Procedure

18	Therapeutics 01/2022 - 01/2003
9	Drug Therapy (Chemotherapy) 01/2022 - 08/2002
4	Gastrectomy 01/2021 - 09/2008
3	Chemoradiotherapy 01/2021 - 08/2016
2	Gastrostomy 03/2022 - 03/2011
2	Ligation 01/2022 - 01/2022
2	Molecular Targeted Therapy 11/2021 - 11/2015
2	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 08/2016
2	Appendectomy 10/2013 - 10/2011